QDEL.NASDAQQuidelortho CORP

Form 4: QuidelOrtho Director Ann D. Rhoads Increases Common Stock Holdings Through RSU Conversion

Sentiment:

Insider Transaction Report


QuidelOrtho Corp Director Ann D. Rhoads has increased her beneficial ownership of common stock by 655 shares through the conversion of restricted stock units.

Summary

  • Ann D. Rhoads, a Director of QuidelOrtho Corp (QDEL), acquired a total of 655 shares of common stock on May 24, 2025.
  • The acquisitions consisted of 546 shares and 109 shares, both at a price of $0.
  • These shares were acquired through the conversion and release of previously reported restricted stock units (RSUs).
  • Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
  • The release of these RSUs was deferred pursuant to QuidelOrtho's deferred compensation program for participating non-employee directors and occurred according to the elected deferred schedule.
  • Following these transactions, Ann D. Rhoads beneficially owns 14,271 shares of QuidelOrtho Corp common stock directly.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While a routine RSU conversion, it represents an increase in direct ownership by a director, which can be viewed favorably as it aligns insider interests with shareholders. There are no negative implications from this specific filing.

Positives

  • The increase in direct common stock ownership by a director, even through RSU conversion, aligns the director's interests more closely with shareholders.
  • The transaction reflects the execution of a pre-existing deferred compensation plan, indicating a structured approach to executive compensation.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future financial performance or strategic outlook.

Industry Context

This filing is a routine insider transaction report and does not provide information relevant to broader industry trends or competitive dynamics within the diagnostics or medical device sectors.

Stakeholder Impact

  • Shareholders: Provides transparency regarding director stock ownership and compensation structure, confirming alignment of interests.

Key Dates

DateDescription
05/24/2025Date of common stock acquisition through RSU conversion.
05/28/2025Date the Form 4 was signed by the attorney-in-fact for Ann D. Rhoads.

Keywords

QuidelOrtho, QDEL, Form 4, Insider Transaction, Stock Ownership, Restricted Stock Units, RSU Conversion, Director Holdings, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.